{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T22:44:45Z","timestamp":1784241885994,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T00:00:00Z","timestamp":1652054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T00:00:00Z","timestamp":1652054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"IRCCS San Raffaele Ospital Milan. Italy COVID-19 program project grant"},{"DOI":"10.13039\/501100003197","name":"Ministry of Health, Italy | Agenzia Italiana del Farmaco, Ministero della Salute","doi-asserted-by":"crossref","award":["COVID-2020-12371617"],"award-info":[{"award-number":["COVID-2020-12371617"]}],"id":[{"id":"10.13039\/501100003197","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Infectious and inflammatory stimuli elicit the generation of chitinase-3-like protein-1 (CHI3L1), involved in tissue damage, repair and remodeling. We evaluated whether plasma CHI3L1 at disease onset predicts clinical outcome of patients with Coronavirus 2019 (COVID-19) disease. Blood from 191 prospectively followed COVID-19 patients were collected at hospital admission between March 18th and May 5th, 2020. Plasma from 80 survivors was collected one month post-discharge. Forty age- and sex-matched healthy volunteers served as controls. Primary outcome was transfer to intensive care unit (ICU) or death. CHI3L1 was higher in COVID-19 patients than controls (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001). Patients with unfavorable outcome (41 patients admitted to ICU, 47 died) had significantly higher CHI3L1 levels than non-ICU survivors (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001). CHI3L1 levels abated in survivors one month post-discharge, regardless of initial disease severity (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001), although remaining higher than controls (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). Cox regression analysis revealed that CHI3L1 levels predict primary outcome independently of age, sex, comorbidities, degree of respiratory insufficiency and systemic inflammation or time from symptom onset to sampling (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001). Kaplan\u2013Meier curve analysis confirmed that patients with CHI3L1 levels above the median (361\u00a0ng\/mL) had a poorer prognosis (log rank test, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001). Plasma CHI3L1 is increased in COVID-19 patients and predicts adverse outcome.<\/jats:p>","DOI":"10.1038\/s41598-022-11532-x","type":"journal-article","created":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T17:23:40Z","timestamp":1652117020000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Chitinase-3-like protein-1 at hospital admission predicts COVID-19 outcome: a prospective cohort study"],"prefix":"10.1038","volume":"12","author":[{"given":"Rebecca","family":"De Lorenzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Sciorati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola I.","family":"Lor\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Capobianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Tresoldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6415-1535","authenticated-orcid":false,"given":"Daniela M.","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Ciceri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Rovere-Querini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo A.","family":"Manfredi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,9]]},"reference":[{"key":"11532_CR1","doi-asserted-by":"publisher","first-page":"155389","DOI":"10.1016\/j.cyto.2020.155389","volume":"138","author":"S Bulow Anderberg","year":"2021","unstructured":"Bulow Anderberg, S. et al. Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients. Cytokine 138, 155389 (2021).","journal-title":"Cytokine"},{"issue":"1","key":"11532_CR2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s10020-020-00230-x","volume":"26","author":"Y Chen","year":"2020","unstructured":"Chen, Y. et al. IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19. Mol. Med. 26(1), 97 (2020).","journal-title":"Mol. Med."},{"key":"11532_CR3","doi-asserted-by":"publisher","DOI":"10.23736\/S0031-0808.20.04168-3","author":"P Rovere-Querini","year":"2020","unstructured":"Rovere-Querini, P. et al. Biobanking for COVID-19 research. Panminerva Med. https:\/\/doi.org\/10.23736\/S0031-0808.20.04168-3 (2020).","journal-title":"Panminerva Med."},{"key":"11532_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40364-020-00217-0","volume":"8","author":"C Danwang","year":"2020","unstructured":"Danwang, C. et al. A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19). Biomark. Res. 8, 37 (2020).","journal-title":"Biomark. Res."},{"issue":"7821","key":"11532_CR5","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","volume":"584","author":"C Lucas","year":"2020","unstructured":"Lucas, C. et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature 584(7821), 463\u2013469 (2020).","journal-title":"Nature"},{"issue":"10","key":"11532_CR6","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1002\/jmv.26050","volume":"92","author":"W Tian","year":"2020","unstructured":"Tian, W. et al. Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis. J. Med. Virol. 92(10), 1875\u20131883 (2020).","journal-title":"J. Med. Virol."},{"issue":"1","key":"11532_CR7","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jaci.2020.04.027","volume":"146","author":"Y Yang","year":"2020","unstructured":"Yang, Y. et al. Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19. J. Allergy Clin. Immunol. 146(1), 119-127.e4 (2020).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"11","key":"11532_CR8","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1164\/rccm.202005-1885OC","volume":"202","author":"S Hue","year":"2020","unstructured":"Hue, S. et al. Uncontrolled innate and impaired adaptive immune responses in patients with COVID-19 acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 202(11), 1509\u20131519 (2020).","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"7865","key":"11532_CR9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41586-021-03570-8","volume":"595","author":"TM Delorey","year":"2021","unstructured":"Delorey, T. M. et al. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets. Nature 595(7865), 107\u2013113 (2021).","journal-title":"Nature"},{"issue":"8","key":"11532_CR10","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1161\/CIRCRESAHA.121.317997","volume":"128","author":"MK Chung","year":"2021","unstructured":"Chung, M. K. et al. COVID-19 and cardiovascular disease: From bench to bedside. Circ. Res. 128(8), 1214\u20131236 (2021).","journal-title":"Circ. Res."},{"issue":"4","key":"11532_CR11","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2021.01.007","volume":"184","author":"A Sette","year":"2021","unstructured":"Sette, A. & Crotty, S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell 184(4), 861\u2013880 (2021).","journal-title":"Cell"},{"issue":"1","key":"11532_CR12","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41392-020-00303-7","volume":"5","author":"T Zhao","year":"2020","unstructured":"Zhao, T. et al. Chitinase-3 like-protein-1 function and its role in diseases. Signal Transduct. Target. Ther. 5(1), 201 (2020).","journal-title":"Signal Transduct. Target. Ther."},{"key":"11532_CR13","doi-asserted-by":"crossref","unstructured":"Kamle, S. et al. Chitinase 3-like-1 is a Therapeutic target that mediates the effects of aging in COVID-19. bioRxiv: the preprint server for biology, 20, 124 (2021).","DOI":"10.1101\/2021.01.05.425478"},{"issue":"2","key":"11532_CR14","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181(2), 271-280.e8 (2020).","journal-title":"Cell"},{"issue":"7","key":"11532_CR15","doi-asserted-by":"publisher","first-page":"e9610","DOI":"10.15252\/msb.20209610","volume":"16","author":"F Hikmet","year":"2020","unstructured":"Hikmet, F. et al. The protein expression profile of ACE2 in human tissues. Mol. Syst. Biol. 16(7), e9610 (2020).","journal-title":"Mol. Syst. Biol."},{"key":"11532_CR16","doi-asserted-by":"publisher","first-page":"102976","DOI":"10.1016\/j.ebiom.2020.102976","volume":"60","author":"ME Ortiz","year":"2020","unstructured":"Ortiz, M. E. et al. Heterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 in the human respiratory tract. EBioMedicine 60, 102976 (2020).","journal-title":"EBioMedicine"},{"issue":"1","key":"11532_CR17","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13054-020-03383-7","volume":"25","author":"L Schoneveld","year":"2021","unstructured":"Schoneveld, L. et al. YKL-40 as a new promising prognostic marker of severity in COVID infection. Crit. Care 25(1), 66 (2021).","journal-title":"Crit. Care"},{"key":"11532_CR18","doi-asserted-by":"publisher","first-page":"108509","DOI":"10.1016\/j.clim.2020.108509","volume":"217","author":"F Ciceri","year":"2020","unstructured":"Ciceri, F. et al. Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy. Clin. Immunol. 217, 108509 (2020).","journal-title":"Clin. Immunol."},{"issue":"10","key":"11532_CR19","doi-asserted-by":"publisher","first-page":"e0239570","DOI":"10.1371\/journal.pone.0239570","volume":"15","author":"R De Lorenzo","year":"2020","unstructured":"De Lorenzo, R. et al. Residual clinical damage after COVID-19: A retrospective and prospective observational cohort study. PLoS ONE 15(10), e0239570 (2020).","journal-title":"PLoS ONE"},{"key":"11532_CR20","doi-asserted-by":"publisher","first-page":"105114","DOI":"10.1016\/j.phrs.2020.105114","volume":"161","author":"N Farina","year":"2020","unstructured":"Farina, N. et al. COVID-19: Pharmacology and kinetics of viral clearance. Pharmacol. Res. 161, 105114 (2020).","journal-title":"Pharmacol. Res."},{"key":"11532_CR21","first-page":"22","volume":"91","author":"P Rovere Querini","year":"2020","unstructured":"Rovere Querini, P. et al. Post-COVID-19 follow-up clinic: Depicting chronicity of a new disease. Acta Bio Med. Atenei Parm. 91, 22\u201328 (2020).","journal-title":"Acta Bio Med. Atenei Parm."},{"issue":"10","key":"11532_CR22","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1111\/j.1537-2995.2006.00976.x","volume":"46","author":"ME Darnell","year":"2006","unstructured":"Darnell, M. E. & Taylor, D. R. Evaluation of inactivation methods for severe acute respiratory syndrome coronavirus in noncellular blood products. Transfusion 46(10), 1770\u20131777 (2006).","journal-title":"Transfusion"},{"key":"11532_CR23","doi-asserted-by":"publisher","first-page":"4436","DOI":"10.1007\/s00415-021-10595-6","volume":"268","author":"R De Lorenzo","year":"2021","unstructured":"De Lorenzo, R. et al. Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients. J. Neurol. 268, 4436\u20134442 (2021).","journal-title":"J. Neurol."},{"issue":"5","key":"11532_CR24","doi-asserted-by":"publisher","first-page":"e0251924","DOI":"10.1371\/journal.pone.0251924","volume":"16","author":"D Maguire","year":"2021","unstructured":"Maguire, D. et al. The systemic inflammatory response and clinicopathological characteristics in patients admitted to hospital with COVID-19 infection: Comparison of 2 consecutive cohorts. PLoS ONE 16(5), e0251924 (2021).","journal-title":"PLoS ONE"},{"issue":"1","key":"11532_CR25","doi-asserted-by":"publisher","first-page":"14471","DOI":"10.1038\/s41598-021-93950-x","volume":"11","author":"TP Velavan","year":"2021","unstructured":"Velavan, T. P. et al. Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients. Sci. Rep. 11(1), 14471 (2021).","journal-title":"Sci. Rep."},{"key":"11532_CR26","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.147472","author":"KA Queisser","year":"2021","unstructured":"Queisser, K. A. et al. COVID-19 generates hyaluronan fragments that directly induce endothelial barrier dysfunction. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.147472 (2021).","journal-title":"JCI Insight"},{"key":"11532_CR27","doi-asserted-by":"publisher","first-page":"698169","DOI":"10.3389\/fmicb.2021.698169","volume":"12","author":"AD Proal","year":"2021","unstructured":"Proal, A. D. & VanElzakker, M. B. Long COVID or Post-acute sequelae of COVID-19 (PASC): An overview of biological factors that may contribute to persistent symptoms. Front. Microbiol. 12, 698169 (2021).","journal-title":"Front. Microbiol."},{"issue":"7","key":"11532_CR28","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1136\/emermed-2020-210380","volume":"38","author":"DT Arnold","year":"2021","unstructured":"Arnold, D. T. et al. Predicting outcomes of COVID-19 from admission biomarkers: a prospective UK cohort study. Emerg. Med. J. EMJ 38(7), 543\u2013548 (2021).","journal-title":"Emerg. Med. J. EMJ"},{"key":"11532_CR29","doi-asserted-by":"crossref","first-page":"117727192110133","DOI":"10.1177\/11772719211013363","volume":"6","author":"E Donoso-Navarro","year":"2021","unstructured":"Donoso-Navarro, E., Arribas Gomez, I. & Bernabeu-Andreu, F. A. IL-6 and other biomarkers associated with poor prognosis in a cohort of hospitalized patients with COVID-19 in Madrid. Biomark. Insights 6, 11772719211013364 (2021).","journal-title":"Biomark. Insights"},{"issue":"38","key":"11532_CR30","first-page":"016","volume":"20","author":"J De Loor","year":"2016","unstructured":"De Loor, J. et al. Urinary chitinase 3-like protein 1 for early diagnosis of acute kidney injury: A prospective cohort study in adult critically ill patients. Crit. Care 20(38), 016\u20131192 (2016).","journal-title":"Crit. Care"},{"issue":"1","key":"11532_CR31","doi-asserted-by":"publisher","first-page":"018","DOI":"10.1186\/s12936-018-2225-5","volume":"17","author":"AL Conroy","year":"2018","unstructured":"Conroy, A. L. et al. Chitinase-3-like 1 is a biomarker of acute kidney injury and mortality in paediatric severe malaria. Malar. J. 17(1), 018\u20132225 (2018).","journal-title":"Malar. J."},{"issue":"2","key":"11532_CR32","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s40620-021-00997-0","volume":"34","author":"C Lanzani","year":"2021","unstructured":"Lanzani, C. et al. Role of blood pressure dysregulation on kidney and mortality outcomes in COVID-19. Kidney, blood pressure and mortality in SARS-CoV-2 infection. J. Nephrol. 34(2), 305\u2013314 (2021).","journal-title":"J. Nephrol."},{"key":"11532_CR33","doi-asserted-by":"publisher","DOI":"10.23736\/S0031-0808.21.04399-8","author":"R De Lorenzo","year":"2021","unstructured":"De Lorenzo, R. et al. Physical and psychological sequelae at three months after acute illness in COVID-19 survivors. Panminerva Med. https:\/\/doi.org\/10.23736\/S0031-0808.21.04399-8 (2021).","journal-title":"Panminerva Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-11532-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-11532-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-11532-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T02:38:40Z","timestamp":1669343920000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-11532-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,9]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["11532"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-11532-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,9]]},"assertion":[{"value":"10 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7606"}}